Elis Pharmaceuticals (India) Private Limited

Elis Pharmaceuticals (India) Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U85121DL2006PTC152273 Incorporated 21 August 2006 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹3.87 Cr
▲ 18% YoY
Net loss · FY 2024
₹2.15 Lakh
Net margin -0.6%
EBITDA · FY 2024
₹25.3 Lakh
EBITDA margin 6.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7 Lakh
Issued & subscribed
Open charges
₹26.08 Lakh
Secured borrowings
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings

About Elis Pharmaceuticals (India) Private Limited

Data last updated:

Elis Pharmaceuticals (India) Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 August 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC152273. Its GSTIN is 07AABCE9429R1ZX (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7 Lakh. It is led by directors Sapna Kulwant Kaushik and Ajay Prem Juneja.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No Wz – 508/6 Kh No 1529 1st Floor, Blk – Wz Village Basai Darapur Landmark Near Govt School, New Delhi, Delhi, India – 110015.

As per the financials filed for FY 2024, the company reported a revenue of ₹3.87 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹2.15 Lakh (net margin -0.6%) and EBITDA of ₹25.3 Lakh (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 2% over five years.

As per MCA filings, the company has open charges of ₹26.08 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.

Elis Pharmaceuticals (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0003107). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elispharma.org.

Company details

CIN U85121DL2006PTC152273
Registration Number 152273
Incorporation Date 21 August 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0003107
Key People
Sapna Kulwant Kaushik Director Ajay Prem Juneja Director

Recognitions & Rankings of Elis Pharmaceuticals (India)

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-11-0003107

Contact details

Elis Pharmaceuticals (India) Private Limited's registered office is in New Delhi, Delhi. Its website is elispharma.org. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    elispharma.org
  • Registered Address
    House No Wz – 508/6 Kh No 1529 1st Floor, Blk – Wz Village Basai Darapur Landmark Near Govt School, New Delhi, Delhi, India – 110015
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Elis Pharmaceuticals (India) Private Limited, buy the company report.

Comprehensive company report
Elis Pharmaceuticals (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Elis Pharmaceuticals (India) is manufacturing. In detail, this covers manufacture of chemicals and chemical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing20Manufacture of chemicals and chemical products

To see the full business activity and turnover split of Elis Pharmaceuticals (India) Private Limited, buy the company report.

Financials of Elis Pharmaceuticals (India) Private Limited

FY 2025 filings available

Elis Pharmaceuticals (India) Private Limited reported revenue of ₹3.87 Cr (up 18% YoY) for FY 2024.

Revenue · FY 2024
₹3.87 Cr ▲ 18%
Net loss · FY 2024
₹2.15 Lakh margin -0.6%
EBITDA · FY 2024
₹25.3 Lakh margin 6.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 3%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 2%
5 years · compounded
▼ 1%

Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 18% growth in the latest year. EBITDA rose 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹25.3 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.15 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin6.5%
Net Profit Margin-0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Elis Pharmaceuticals (India) Private Limited, buy the company report.

Board of directors of Elis Pharmaceuticals (India) Private Limited

Elis Pharmaceuticals (India) has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sapna Kulwant KaushikDirector21 Apr 20224 Years 6 MonthsCurrent
Ajay Prem Juneja
Also directs: Lembos Pharmaceuticals LLP, Azpara Infra Projects LLP, Azpara's Tapovan LLP and 1 more
Director01 Mar 201412 Years 8 MonthsCurrent
View all directors

Auditor

Elis Pharmaceuticals (India) Private Limited is audited by V.K KHOSLA & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
V.K KHOSLA & CO.FY 202302283N

Shareholding

The shareholding of Elis Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Elis Pharmaceuticals (India) Private Limited, buy the company report.

Charges & borrowings

Open charges
₹26.08 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.16 Cr
Axis Bank Limited₹0.10 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
18 Oct 2021100508783Hdfc Bank Limited₹16.08 LakhOpen
19 Jul 2021100466007Axis Bank Limited₹10 LakhOpen

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Elis Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Elis Pharmaceuticals (India) has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AABCE9429R1ZXDelhiActive01 Jul 2017
05AABCE9429R1Z1UttarakhandActive03 Mar 2021

To see the full GST registrations and return filing status of Elis Pharmaceuticals (India) Private Limited, buy the company report.

Recent activity

Elis Pharmaceuticals (India) Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Sapna Kulwant Kaushik ceased to be Additional Director on 30 Sep 2022.

AGM
Elis Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elis Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Sapna Kulwant Kaushik ceased to be Additional Director.
Ceased
Madan Lal Juneja ceased to be Director.
Appointed
Sapna Kulwant Kaushik was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 16.08 Lakh with Charge ID 100508783 was registered on 18 Oct 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 10.00 Lakh with Charge ID 100466007 was registered on 19 Jul 2021.
Ceased
Deepak Juneja ceased to be Director.
Appointed
Ajay Prem Juneja was appointed as Director.
Incorporation
21 Aug 2006
Elis Pharmaceuticals (India) Private Limited was registered on 21 Aug 2006 with Roc Delhi & aged 20 years 2 months as per MCA records.

Frequently asked questions

Elis Pharmaceuticals (India) is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 August 2006 (20+ years old) and is registered under CIN U85121DL2006PTC152273.

Elis Pharmaceuticals (India) has 2 current directors:

The latest financial statements of Elis Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Elis Pharmaceuticals (India) is 07AABCE9429R1ZX, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 05AABCE9429R1Z1 (Uttarakhand).

The CIN (Corporate Identification Number) of Elis Pharmaceuticals (India) is U85121DL2006PTC152273. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elis Pharmaceuticals (India) has 2 court cases on record: 2 filed by the company. 1 is pending.

Elis Pharmaceuticals (India) was incorporated on 21 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.

Sapna Kulwant Kaushik ceased to be Additional Director on 30 Sep 2022. Madan Lal Juneja ceased to be Director on 22 Apr 2022. Sapna Kulwant Kaushik was appointed as Director on 21 Apr 2022. Elis Pharmaceuticals (India) has 5 board changes on record in total.

Yes, Elis Pharmaceuticals (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0003107).

Elis Pharmaceuticals (India) can be reached through the website elispharma.org. Its registered office is in New Delhi, Delhi, India.